caspase-7 siRNA and shRNA Plasmids (m)

(0)

Species	Gene Name	Gene ID	Chromosome Location	Isoform (mRNA) Accession #	Protein Accession #	OMIM™ Number
Mouse	Casp7	12369	19 D2	XM_006526616, NM_007611	P97864	N/A

Description

10 µM, 50-100 transfections
siRNA products generally consist of pools of three to five target-specific 19-25 nt siRNAs designed to knockdown gene expression
for independent verification of caspase-7 gene silencing results, individual siRNA duplex components are also available upon request
suitable control antibody: caspase-7 p10 Antibody (B-3): sc-365034
sqRT-PCR Primer also available: caspase-7 (m)-PR: sc-29928-PR, 20 µl
Get details about si/shRNA Gene Silencers

See Protocol Online.

DOWNLOADS

QUICK LINKS

Description

20 µl of each primer set is provided at a concentration of 10 µM
caspase-7 Primer (m) includes A set (forward & reverse) and B set (forward & reverse) primers
Primer sets are recommended for semi-quantitative nested reverse transcriptase PCR

See Protocol Online.

DOWNLOADS

QUICK LINKS

Description

20 µg, up to 20 transfections
shRNA Plasmids generally consist of a pool of three to five lentiviral vector plasmids each encoding target-specific 19-25 nt (plus hairpin) shRNAs designed to knockdown gene expression
shRNA sequences correspond to caspase-7 siRNA Gene Silencer sequences
provided as transfection-ready purified plasmid DNA target-specific gene silencing
after transfection, cells stably expressing shRNAs can be isolated by puromycin selection
shRNA Plasmids are intended only for non-commercial use.
suitable control antibody: caspase-7 p10 Antibody (B-3): sc-365034
sqRT-PCR Primer also available: caspase-7 (m)-PR: sc-29928-PR, 20 µl

See Protocol Online.

DOWNLOADS

QUICK LINKS

Description

200 µl viral stock containing 1x 10⁶ infectious units of virus (IFU) , sufficient for 10-20 transductions
Lentiviral Particles are provided as transduction-ready viral particles for gene silencing
Lentiviral Particles generally contain three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin) shRNA designed to knockdown gene expression
shRNA sequences correspond to caspase-7 siRNA Gene Silencer sequences
After transduction, stable cell lines expressing the shRNA may be isolated via selection with puromycin
Biosafety - Lentiviral Particles are replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells.
Lentiviral Particles are intended for non-commercial use.

See Protocol Online.

DOWNLOADS

QUICK LINKS